SU614746A3 - Method of obtaining prostaglandine analogue - Google Patents

Method of obtaining prostaglandine analogue

Info

Publication number
SU614746A3
SU614746A3 SU762334454A SU2334454A SU614746A3 SU 614746 A3 SU614746 A3 SU 614746A3 SU 762334454 A SU762334454 A SU 762334454A SU 2334454 A SU2334454 A SU 2334454A SU 614746 A3 SU614746 A3 SU 614746A3
Authority
SU
USSR - Soviet Union
Prior art keywords
formula
ethyl
acid
methyl
solution
Prior art date
Application number
SU762334454A
Other languages
Russian (ru)
Inventor
Жан Ален
Пижероль Шарль
Эймар Пьер
Симиан Жак
Original Assignee
Лябаз С.А., (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лябаз С.А., (Фирма) filed Critical Лябаз С.А., (Фирма)
Application granted granted Critical
Publication of SU614746A3 publication Critical patent/SU614746A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/04—Saturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/16—Saturated compounds containing keto groups bound to acyclic carbon atoms containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/377—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • C07C51/38—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups by decarboxylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/005—Compounds containing elements of Groups 1 or 11 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Description

(54) СПОСОБ ПОЛУЧЕНИЯ АНАЛОГА ПЬХЮТАГЛЛИДИИА(54) METHOD OF OBTAINING ANALOGUE PHUHUTAGLLIDIA

II

Иэобрегенне относитс  к способу получени  не описанного в литературе аналога простаглаидина формулыIobregenne does not relate to a method for producing a prostaglaidin analogue of the formula not described in literature.

Предлагаемый способ получени  aiianoi-,i простагландина заключаетс  в rovf, что (;лс жный эфир обшей формулы 1The proposed method for the preparation of aiianoi-, i prostaglandin consists in rovf that (; ester of the general formula 1

СООНCun

соонsoon

10ten

онhe

обладающего фармакологической активностью.with pharmacological activity.

Известен способ получени  карбоновых кислот с помощью щелочного гидролиза сложных эфиров ij.A known method for producing carboxylic acids by alkaline hydrolysis of esters ij.

Использование известной реакции позвол ет получать новое производное простаглаи-20 диИа, про вл ющее фармакологическую активность.The use of a known reaction allows the preparation of a new prostaglai-20 diIa derivative exhibiting pharmacological activity.

иель изобретени  - расщиреиие ассортимеита биологически активных соедииеинй. 25The invention of the invention is the expansion of the assortite of biologically active compounds. 25

в которой и представл ет собой линейшлй или разветвленный алкнльиый радикпл, содержащий 1-7 атомов углерода, пооверглюг взаимодействию с гидроокисью щелочно1Х металла в спиртовой среде при комнатной температуре с последующей обработкой сил ной кислотой.in which it represents a linear or branched alkali radikpl containing 1-7 carbon atoms, interacting with an alkali metal hydroxide in an alcohol medium at room temperature followed by treatment with strong acid.

Соединени  формулы Т, в которой Tt п|х.лставл ет ообой метил нли этил, могут быть получены восстанхжлением 3)L - uu-карбометокси- или карбэтокси-1-гексип-5-(3-(Ж(:о-1-октен- Еj-Bin )-2-пирролидинона обшей формулы ДCompounds of formula T in which Tt p | x. Represents methyl methyl or ethyl can be obtained by reduction 3) L - u-carbomethoxy or carbethoxy-1-hexyp-5- (3- (W (: o-1- octene-Ej-Bin) -2-pyrrolidinone of the general formula D

ClOORCloor

R которой Т -метил или атнл, с помощью подход щего восстановител , например бо(гидрида натри , в инертной среде, например диметокснэтане, при , предпочтительно 0°С.R of which T is methyl or atnl, using a suitable reducing agent, for example bo (sodium hydride, in an inert medium, for example dimethoxynethane, with, preferably 0 ° C.

Соединени  могут быть получены из DI -пироглутаминовЫ кислоты ф( мулыCompounds can be obtained from DI-pyroglutamic acids f (mules

(J(J

7«Н7 "H

Соон Soon

этерификацией последней этанолом в присутствии кислоты, например п олуолсуль- фоювой, получают этил-пироглутамат формулыby esterification of the latter with ethanol in the presence of an acid, for example, p-olusulfonic, ethyl pyroglutamate of the formula

ОABOUT

NHNH

ид.id

который затем восстанавливают б гидрндом натри  в растворвтело,. например метаноле, получа  (жсиметил-2-пирропидинон формулыwhich is then reduced with sodium hydrnd in solution, in body ,. for example, methanol to obtain (zsimethyl-2-pyrropidinone of the formula

IоIo

тшtsh

i-Li-l

СНгОНSNGON

Затем это соединение подвергают взаимо Действию с 2,3-дигндрс«тираном в инертной среде, например хлористом метилене, в присутствии кислоты, например ,п- олуолсуль- фоновой, и получают DU -5-(гвтрагидр пиранил-2-сжсиметил )-2-пирролидинон формулыThis compound is then reacted with a 2,3-diggers "tyrant in an inert medium, for example, methylene chloride, in the presence of an acid, for example, p-oluolsulfonic), to give DU-5- (pyrayl-2-ssimethyl) -2 -pyrrolidinone formula

ОABOUT

IXIx

«„о""about

который обрабатывают метил- или 9тил-7-бромгептаноатом обшей which is treated with methyl or 9-7-bromoheptanoate sheath

)4Вг,) 4Vg,

где R имеет те же значени , что и в формуле JT , в инертном растворителе,, предпочтительно толуоле, в присутствии амида натри , и выдел ют соединени  общей формулы jjwhere R has the same meaning as in formula JT, in an inert solvent, preferably toluene, in the presence of sodium amide, and compounds of the general formula jj are isolated

СООЕ Sooe

СИ, о-/ЛSI, o- / l

Ов которой т имеет те же значени , что и в формуле Н .Oh which t has the same meaning as in the formula.

3)Ь-и;-Карбометокси- или карбэтокси-1-гексил-51 тетрагндропйранил-2-сжсиметил)- -2-пирролидинон формулы Ц гидропиауют в кислой среде, например в сс п ной кислоте , в присутствии растворител , например метанола, и получают I)L -ч -карбометокси- или карбэтокси-i-гексил-б-оксиметил- -2-пирролидинон обивй формуль 3) L-and; -Carbomethoxy- or carbethoxy-1-hexyl-51 tetrahydropyranyl-2-ssimethyl) -2-pyrrolidinone of the formula C is hydropiated in an acidic medium, for example, with sulfuric acid, in the presence of a solvent, for example methanol, and get I) L-h -carbomethoxy- or carbethoxy-i-hexyl-b-hydroxymethyl -2 -2-pyrrolidinone obiv formul

эоeo

С ООНFrom the UN

3535

СНгОнSNGon

в которой т имеет те же значени , что и в формуле Я , затем первичный спирт, окисл ют до альдегида в инертной среде, например бензоле, при комбинированном воздействии диметилсульфоксида, дициклогексилкарбодиимида и дихлоруксусной кисS лоты, получаю т Ли-Ш-карбометокси- или карбэтокси-1-гексил-5-«арбоксальдегид-2-пирролидинон формулыwherein t has the same meaning as in formula I, then primary alcohol, is oxidized to the aldehyde in an inert medium, for example benzene, when combined with dimethyl sulfoxide, dicyclohexylcarbodiimide and dichloroacetic acid, get t-Li-Sh-carbomethoxy or carbethoxy -1-hexyl-5- "arboxaldehyde-2-pyrrolidinone of the formula

COORCOOR

СноSno

5Л В которой т имеет те же значени , что и в формуле Д . Альдегидную группу в синтезированном соединении подвергают реакции Виттига с 1-трифени/|фосфоранилиден-2-геитаноном формулы IV5L In which m has the same meanings as in formula D. The aldehyde group in the synthesized compound is subjected to the Wittig reaction with 1-tripheny / phosphoranylidene-2-geitanone of formula IV

Claims (1)

(CfcH«),P CHCOC,H . с тем, чтобы получить соответственно DL-Ш -карбом«гокси- или карбэтоксн-1-гексил- -5-(3-oкco-l-oктeн- EJ-ил)-2-пирролидинон формулы И . Метил- или этил-7-бромгептаноат можно получить из пробковой кислоты (октаидиоеой кислоты), которую перевод т в ме тилсжый или этиловый моноэфир, затем обр батывают эфир нитратом серебра, получают метил- или этилсуберат серебра и о рабатывают соль бромом в инертной среде, например четыреххлористом углероде. Фосфорсодержащее соединение формулы W может быть получено из дипентилкадми  (получают из пентилмагнийбромида и хлористого кадми ) и монохлорацетилхлорида. Полученный 1-хлор-2-гептан он обрабатывают трифенилфосфином, образующийс  трифенил-2-оксогептилфосфорийхлорид формулы ( t6H5)3PCH2 ioC5HiiCr с помощью водного раствора поташа перево д т в соединение формулы IV . Другие сложные эфиры формулы I могут быть получены по методике, приведенной выше дл  приготовлени  метилгжых и этиловых эфир ОБ формулы I . Пример. ПолученнеЭи - UU- арбсжси-1-гексил-5 (З-окси-1-октек )-2-пирролидинона или DL -8-аза-11-деокси-ПГЕ . В круглодонную трехгорлую колбу емкс стью 250 мл, снабженную кеханической мешалкой, валивают 1ОО мл метанола и 2,6 г Dl,-u -кapбoмeтoкcи-l-гeкcил-5-lЗrOкcи-l-oктeн- E -ил )-2-пиppoлидинoнa. Образовавшийс  раствор охла аают на бане с лед нсй водой до О С, затем медленно пр ливают 40 мл 0,5 н. раствора едкого натра оставл ют на 2,5 ч при комнатной температуре , добавл ют 20 мл воды, полученный водный раствор промывают 25%-ным раство ром сол нсй кислоты до рН 2 и несколько раз экстрагируют этилацетатом. Органические фазы соедин ют, промывают насыщенным раствором хлористого натри , сушат и удал ют растворитель, Пол чают 2,1 г Ш5%) целевого соединени  в виде частично o.iкристаллизсдаавшегос  гигроскопичного ix-nii. Хроматографи  в тонком слое силика1х ли с применением смеси бензол-аиоксап-уксусна  кислота (90:25:4) дает основное п тно Т f 0,3 и два п тна с Я О,39 и 1 соотетственно . ИК-спектр 1хлороформ), см , 1710 1С-0), 1665 (CO-N). Формула изобретений 1. Способ получени  аналога простагланина формулы отличающийс  тем, что сложный эфир обшвй формулы В которой т представл ет линейный или разветвленный алкильный радикал, содержащий 1-7 атомов углерода, подвергают взаимодействию с гидроокисью щелочного металла в спиртовой среде при комнатной температуре с последующей обработкой сильней . кислотой, после чего целевой продукт выдел ют. Источники информйции, прин тые во внимание при жсспертизе: 1. Вайганд-Хельгетаг.Методы эксперимента в органической химии, М., Хими ;, с. 366, 1968.(CfcH "), P CHCOC, H. so as to obtain, respectively, the DL-III-carb "goxy- or carbethox-1-hexyl-5- (3-occo-1-octen-EJ-yl) -2-pyrrolidinone of the formula I. Methyl or ethyl 7-bromoheptanoate can be obtained from corky acid (octaic acid), which is converted into methyl or ethyl monoether, then treated with ether with silver nitrate, silver methyl or ethyl suber is obtained and the salt is worked up with bromine in an inert medium, for example carbon tetrachloride. The phosphorus-containing compound of the formula W can be obtained from diphenylcadmi (obtained from pentylmagnesium bromide and cadmium chloride) and monochloroacetyl chloride. The resulting 1-chloro-2-heptane is treated with triphenylphosphine, which forms triphenyl-2-oxoheptylphosphoric chloride of the formula (t6H5) 3PCH2 ioC5HiiCr using an aqueous solution of potash to a compound of formula IV. Other esters of formula I can be prepared according to the procedure outlined above for the preparation of methyl ether and ethyl ester ABOUT formula I. Example. The resulting EE is UU-arbs-1-hexyl-5 (3-hydroxy-1-octec) -2-pyrrolidinone or DL-8-aza-11-deoxy-PGE. In a round-bottom three-neck flask with a capacity of 250 ml, equipped with a mechanical stirrer, 1OO ml of methanol and 2.6 g of Dl, -i-carbox-1-hexyl-5-3-oxy-1-pyropolydone are poured. The resulting solution is cooled in an ice-water bath to 0 ° C, then 40 ml 0.5N is slowly poured. sodium hydroxide solution is left for 2.5 hours at room temperature, 20 ml of water are added, the resulting aqueous solution is washed with a 25% solution of hydrochloric acid to pH 2 and extracted several times with ethyl acetate. The organic phases are combined, washed with a saturated solution of sodium chloride, dried and the solvent is removed. Obtain 2.1 g of the 5 5%) target compound as a partially o. Crystallization of the hygroscopic ix-nii given. Chromatography in a thin layer of silica gel using a mixture of benzene-aioxap-acetic acid (90: 25: 4) gives the main spot T f 0.3 and two spots with I O, 39 and 1 respectively. IR spectrum of 1 chloroform), cm, 1710 1C-0), 1665 (CO-N). Claims 1. A method for producing a prostaglanin analogue of a formula in which the general ester of formula B contains a linear or branched alkyl radical containing 1-7 carbon atoms and is reacted with an alkali metal hydroxide in an alcoholic medium at room temperature followed by treatment. is stronger. acid, after which the desired product is isolated. Sources of information taken into account when testing: 1. Vaigand-Helgetag. Experimental methods in organic chemistry, M., Himi;, p. 366, 1968.
SU762334454A 1975-03-21 1976-03-19 Method of obtaining prostaglandine analogue SU614746A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB12034/75A GB1529852A (en) 1975-03-21 1975-03-21 8-azaprostaglandins and process for the preparation thereof

Publications (1)

Publication Number Publication Date
SU614746A3 true SU614746A3 (en) 1978-07-05

Family

ID=9997230

Family Applications (1)

Application Number Title Priority Date Filing Date
SU762334454A SU614746A3 (en) 1975-03-21 1976-03-19 Method of obtaining prostaglandine analogue

Country Status (26)

Country Link
JP (1) JPS607602B2 (en)
AR (1) AR213172A1 (en)
AT (1) AT348163B (en)
AU (1) AU501105B2 (en)
BE (1) BE839761A (en)
CA (1) CA1076587A (en)
CH (2) CH611881A5 (en)
DE (1) DE2612114A1 (en)
DK (1) DK140937B (en)
ES (2) ES446239A1 (en)
FI (1) FI61692C (en)
FR (1) FR2304340A1 (en)
GB (1) GB1529852A (en)
HU (1) HU173348B (en)
IE (1) IE42966B1 (en)
IT (1) IT1061011B (en)
MX (1) MX3301E (en)
NL (1) NL7602891A (en)
NO (1) NO144147C (en)
NZ (1) NZ180251A (en)
OA (1) OA05279A (en)
PT (1) PT64919B (en)
SE (1) SE418290B (en)
SU (1) SU614746A3 (en)
YU (1) YU73876A (en)
ZA (1) ZA761448B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097489A (en) * 1977-06-17 1978-06-27 The Upjohn Company 9-Deoxy-9α,6-nitrilo or 6,9α-imino-PGF compounds
US5540618A (en) * 1994-10-28 1996-07-30 National University Of Singapore Passive attenuator for shelter protection against explosions
BR0308166A (en) 2002-03-05 2005-01-18 Ono Pharmaceutical Co 8-azaprostaglandin derivative compounds and drugs containing the compounds as active ingredient

Also Published As

Publication number Publication date
FR2304340B1 (en) 1979-06-29
MX3301E (en) 1980-09-03
BE839761A (en) 1976-09-20
CH611881A5 (en) 1979-06-29
ES446239A1 (en) 1977-07-01
DK140937C (en) 1980-05-19
SE7603400L (en) 1976-09-22
GB1529852A (en) 1978-10-25
AT348163B (en) 1979-02-12
IE42966L (en) 1976-09-21
PT64919B (en) 1977-08-24
DE2612114A1 (en) 1976-10-07
FR2304340A1 (en) 1976-10-15
SE418290B (en) 1981-05-18
NO144147B (en) 1981-03-23
FI61692C (en) 1982-09-10
DK140937B (en) 1979-12-10
ATA195676A (en) 1978-06-15
AU501105B2 (en) 1979-06-14
FI61692B (en) 1982-05-31
ZA761448B (en) 1977-03-30
AR213172A1 (en) 1978-12-29
IT1061011B (en) 1982-10-20
IE42966B1 (en) 1980-11-19
NL7602891A (en) 1976-09-23
YU73876A (en) 1982-10-31
HU173348B (en) 1979-04-28
DK88276A (en) 1976-09-22
ES458389A1 (en) 1978-02-16
FI760744A (en) 1976-09-22
AU1189976A (en) 1977-09-15
CA1076587A (en) 1980-04-29
NO760994L (en) 1976-09-22
OA05279A (en) 1981-02-28
JPS51138671A (en) 1976-11-30
NZ180251A (en) 1978-07-28
CH611604A5 (en) 1979-06-15
NO144147C (en) 1981-07-15
PT64919A (en) 1976-04-01
JPS607602B2 (en) 1985-02-26

Similar Documents

Publication Publication Date Title
FI77847C (en) Process for the preparation of therapeutically useful alkoxy acid derivatives.
US4539420A (en) Optically active 1-aromatic-group-substituted-1-alkanones and methods for their manufacture
US4119727A (en) Novel 11-desoxy-prostaglandin F2 derivatives
KR20140027905A (en) Processes for preparation of lubiprostone
SU614746A3 (en) Method of obtaining prostaglandine analogue
SU727139A3 (en) Method of preparing optically active 11-desoxy-16-aryl-omega-tetranorprostaglandines or their racemates or their salts
SU430543A1 (en) WAY OF OBTAINING ALKYL ETHER 3
US3883659A (en) 9-Oxaprostaglandin compositions
US3806540A (en) Unsaturated carboxylic acid esters
US4317920A (en) Arylacetic acid derivatives
US4076732A (en) Derivatives of α-(6-carboxyhexyl) furfuryl alcohol
US4568762A (en) 4-Methyl-2-oxo-cyclopentylidene acetic acid and esters thereof
JPH0774194B2 (en) A novel actinonine derivative with physiological activity
EP0640579B1 (en) Process for producing optically active 2-norbornanone
US4009172A (en) 2,3,3A,6,7,7A-Hexahydro-thieno[3,2-b]pyridin-(4H)5-ones
US4103091A (en) Method for the preparation of prostaglandin intermediates from a mold metabolite
US4277401A (en) Total synthesis of 1RS,4SR,5RS-4-(4,8-dimethyl)-5-hydroxy-7-nonen-1-yl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid
US5169959A (en) Free radical-catalyzed synthesis of benzoprostacyclins
US3577455A (en) Tau-butyl-alpha-methyl-gamma-nitro valerate
IE43363B1 (en) Cyclopropane derivatives
US4408066A (en) Methyl cyclopropane-1,3-dicarboxylate
US4188329A (en) Intermediates for the preparation of prostaglandins and prostaglandin analogs from a mold metabolite
US3681391A (en) 1,6 oxidocyclodecapentaene alcohols, aldehydes, and acids
US4385004A (en) Esters of ortho-allylphenol useful for the preparation of arylacetic acid derivatives
SU385428A1 (en) METHOD OF OBTAINING DERIVATIVE ALIPHATIC HALOGEN-CONTAINING UNSATUROUS ACIDS